Rinsho Shinkeigaku (Clinical Neurology)

Brief Clinical Note

Serial neurophysiological and neurophysiological examinations for delayed facial nerve palsy in a patient with Fisher syndrome

Motoyuki Umekawa, M.D.1), Keiko Hatano, M.D., Ph.D.1), Hideyuki Matsumoto, M.D., Ph.D.1), Takahiro Shimizu, M.D.1) and Hideji Hashida, M.D., Ph.D.1)

1)Department of Neurology, Japanese Red Cross Medical Center

The patient was a 47-year-old man who presented with diplopia and gait instability with a gradual onset over the course of three days. Neurological examinations showed ophthalmoplegia, diminished tendon reflexes, and truncal ataxia. Tests for anti-GQ1b antibodies and several other antibodies to ganglioside complex were positive. We made a diagnosis of Fisher syndrome. After administration of intravenous immunoglobulin, the patient's symptoms gradually improved. However, bilateral facial palsy appeared during the recovery phase. Brain MRI showed intensive contrast enhancement of bilateral facial nerves. During the onset phase of facial palsy, the amplitude of the compound muscle action potential (CMAP) in the facial nerves was preserved. During the peak phase, the facial CMAP amplitude was within the lower limit of normal values, or mildly decreased. During the recovery phase, the CMAP amplitude was normalized, and the R1 and R2 responses of the blink reflex were prolonged. The delayed facial nerve palsy improved spontaneously, and the enhancement on brain MRI disappeared. Serial neurophysiological and neuroradiological examinations suggested that the main lesions existed in the proximal part of the facial nerves and the mild lesions existed in the facial nerve terminals, probably due to reversible conduction failure.
Full Text of this Article in Japanese PDF (815K)

(CLINICA NEUROL, 57: 234|237, 2017)
key words: Fisher syndrome, delayed facial nerve palsy, anti-GQ1b antibody, nerve conduction study, blink reflex

(Received: 7-Oct-16)